Global Afatinib Dimaleate Tablets Market Growth 2025-2031
The global Afatinib Dimaleate Tablets market size is predicted to grow from US$ 1107 million in 2025 to US$ 1574 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
Afatinib dimaleate tablets are oral, small-molecule, irreversible tyrosine kinase inhibitors (TKIs) primarily used for treating patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations. Afatinib irreversibly inhibits EGFR, HER2, and HER4 signaling pathways, preventing cancer cell growth and proliferation. Clinical studies have shown that afatinib is highly effective as a first-line treatment for EGFR-mutant NSCLC, particularly in patients with Del19 and L858R mutations. The medication is typically administered orally once daily, with dosage adjustments based on individual patient conditions. Common side effects include diarrhea, skin rash, and stomatitis, and the drug should be used under medical supervision.
United States market for Afatinib Dimaleate Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Afatinib Dimaleate Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Afatinib Dimaleate Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Afatinib Dimaleate Tablets players cover Boehringer Ingelheim, Hansoh Pharmaceutical, Chia Tai Tianqing Pharmaceutical, Yangtze River Pharmaceutical, Qingfeng Pharmaceutical Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Afatinib Dimaleate Tablets Industry Forecast” looks at past sales and reviews total world Afatinib Dimaleate Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Afatinib Dimaleate Tablets sales for 2025 through 2031. With Afatinib Dimaleate Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Afatinib Dimaleate Tablets industry.
This Insight Report provides a comprehensive analysis of the global Afatinib Dimaleate Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Afatinib Dimaleate Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Afatinib Dimaleate Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Afatinib Dimaleate Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Afatinib Dimaleate Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Afatinib Dimaleate Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Afatinib Dimaleate Tablets market?
What factors are driving Afatinib Dimaleate Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Afatinib Dimaleate Tablets market opportunities vary by end market size?
How does Afatinib Dimaleate Tablets break out by Type, by Application?
Afatinib dimaleate tablets are oral, small-molecule, irreversible tyrosine kinase inhibitors (TKIs) primarily used for treating patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations. Afatinib irreversibly inhibits EGFR, HER2, and HER4 signaling pathways, preventing cancer cell growth and proliferation. Clinical studies have shown that afatinib is highly effective as a first-line treatment for EGFR-mutant NSCLC, particularly in patients with Del19 and L858R mutations. The medication is typically administered orally once daily, with dosage adjustments based on individual patient conditions. Common side effects include diarrhea, skin rash, and stomatitis, and the drug should be used under medical supervision.
United States market for Afatinib Dimaleate Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Afatinib Dimaleate Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Afatinib Dimaleate Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Afatinib Dimaleate Tablets players cover Boehringer Ingelheim, Hansoh Pharmaceutical, Chia Tai Tianqing Pharmaceutical, Yangtze River Pharmaceutical, Qingfeng Pharmaceutical Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Afatinib Dimaleate Tablets Industry Forecast” looks at past sales and reviews total world Afatinib Dimaleate Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Afatinib Dimaleate Tablets sales for 2025 through 2031. With Afatinib Dimaleate Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Afatinib Dimaleate Tablets industry.
This Insight Report provides a comprehensive analysis of the global Afatinib Dimaleate Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Afatinib Dimaleate Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Afatinib Dimaleate Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Afatinib Dimaleate Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Afatinib Dimaleate Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Afatinib Dimaleate Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 30mg
- 40mg
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- Hansoh Pharmaceutical
- Chia Tai Tianqing Pharmaceutical
- Yangtze River Pharmaceutical
- Qingfeng Pharmaceutical Group
- Qilu Pharmaceutical
- Kelun Pharmaceutical
- CSPC
What is the 10-year outlook for the global Afatinib Dimaleate Tablets market?
What factors are driving Afatinib Dimaleate Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Afatinib Dimaleate Tablets market opportunities vary by end market size?
How does Afatinib Dimaleate Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Afatinib Dimaleate Tablets Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Afatinib Dimaleate Tablets by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Afatinib Dimaleate Tablets by Country/Region, 2020, 2024 & 2031
2.2 Afatinib Dimaleate Tablets Segment by Type
2.2.1 30mg
2.2.2 40mg
2.2.3 Others
2.3 Afatinib Dimaleate Tablets Sales by Type
2.3.1 Global Afatinib Dimaleate Tablets Sales Market Share by Type (2020-2025)
2.3.2 Global Afatinib Dimaleate Tablets Revenue and Market Share by Type (2020-2025)
2.3.3 Global Afatinib Dimaleate Tablets Sale Price by Type (2020-2025)
2.4 Afatinib Dimaleate Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Afatinib Dimaleate Tablets Sales by Application
2.5.1 Global Afatinib Dimaleate Tablets Sale Market Share by Application (2020-2025)
2.5.2 Global Afatinib Dimaleate Tablets Revenue and Market Share by Application (2020-2025)
2.5.3 Global Afatinib Dimaleate Tablets Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Afatinib Dimaleate Tablets Breakdown Data by Company
3.1.1 Global Afatinib Dimaleate Tablets Annual Sales by Company (2020-2025)
3.1.2 Global Afatinib Dimaleate Tablets Sales Market Share by Company (2020-2025)
3.2 Global Afatinib Dimaleate Tablets Annual Revenue by Company (2020-2025)
3.2.1 Global Afatinib Dimaleate Tablets Revenue by Company (2020-2025)
3.2.2 Global Afatinib Dimaleate Tablets Revenue Market Share by Company (2020-2025)
3.3 Global Afatinib Dimaleate Tablets Sale Price by Company
3.4 Key Manufacturers Afatinib Dimaleate Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Afatinib Dimaleate Tablets Product Location Distribution
3.4.2 Players Afatinib Dimaleate Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AFATINIB DIMALEATE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Afatinib Dimaleate Tablets Market Size by Geographic Region (2020-2025)
4.1.1 Global Afatinib Dimaleate Tablets Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Afatinib Dimaleate Tablets Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Afatinib Dimaleate Tablets Market Size by Country/Region (2020-2025)
4.2.1 Global Afatinib Dimaleate Tablets Annual Sales by Country/Region (2020-2025)
4.2.2 Global Afatinib Dimaleate Tablets Annual Revenue by Country/Region (2020-2025)
4.3 Americas Afatinib Dimaleate Tablets Sales Growth
4.4 APAC Afatinib Dimaleate Tablets Sales Growth
4.5 Europe Afatinib Dimaleate Tablets Sales Growth
4.6 Middle East & Africa Afatinib Dimaleate Tablets Sales Growth
5 AMERICAS
5.1 Americas Afatinib Dimaleate Tablets Sales by Country
5.1.1 Americas Afatinib Dimaleate Tablets Sales by Country (2020-2025)
5.1.2 Americas Afatinib Dimaleate Tablets Revenue by Country (2020-2025)
5.2 Americas Afatinib Dimaleate Tablets Sales by Type (2020-2025)
5.3 Americas Afatinib Dimaleate Tablets Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Afatinib Dimaleate Tablets Sales by Region
6.1.1 APAC Afatinib Dimaleate Tablets Sales by Region (2020-2025)
6.1.2 APAC Afatinib Dimaleate Tablets Revenue by Region (2020-2025)
6.2 APAC Afatinib Dimaleate Tablets Sales by Type (2020-2025)
6.3 APAC Afatinib Dimaleate Tablets Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Afatinib Dimaleate Tablets by Country
7.1.1 Europe Afatinib Dimaleate Tablets Sales by Country (2020-2025)
7.1.2 Europe Afatinib Dimaleate Tablets Revenue by Country (2020-2025)
7.2 Europe Afatinib Dimaleate Tablets Sales by Type (2020-2025)
7.3 Europe Afatinib Dimaleate Tablets Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Afatinib Dimaleate Tablets by Country
8.1.1 Middle East & Africa Afatinib Dimaleate Tablets Sales by Country (2020-2025)
8.1.2 Middle East & Africa Afatinib Dimaleate Tablets Revenue by Country (2020-2025)
8.2 Middle East & Africa Afatinib Dimaleate Tablets Sales by Type (2020-2025)
8.3 Middle East & Africa Afatinib Dimaleate Tablets Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Afatinib Dimaleate Tablets
10.3 Manufacturing Process Analysis of Afatinib Dimaleate Tablets
10.4 Industry Chain Structure of Afatinib Dimaleate Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Afatinib Dimaleate Tablets Distributors
11.3 Afatinib Dimaleate Tablets Customer
12 WORLD FORECAST REVIEW FOR AFATINIB DIMALEATE TABLETS BY GEOGRAPHIC REGION
12.1 Global Afatinib Dimaleate Tablets Market Size Forecast by Region
12.1.1 Global Afatinib Dimaleate Tablets Forecast by Region (2026-2031)
12.1.2 Global Afatinib Dimaleate Tablets Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Afatinib Dimaleate Tablets Forecast by Type (2026-2031)
12.7 Global Afatinib Dimaleate Tablets Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Hansoh Pharmaceutical
13.2.1 Hansoh Pharmaceutical Company Information
13.2.2 Hansoh Pharmaceutical Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.2.3 Hansoh Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Hansoh Pharmaceutical Main Business Overview
13.2.5 Hansoh Pharmaceutical Latest Developments
13.3 Chia Tai Tianqing Pharmaceutical
13.3.1 Chia Tai Tianqing Pharmaceutical Company Information
13.3.2 Chia Tai Tianqing Pharmaceutical Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.3.3 Chia Tai Tianqing Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Chia Tai Tianqing Pharmaceutical Main Business Overview
13.3.5 Chia Tai Tianqing Pharmaceutical Latest Developments
13.4 Yangtze River Pharmaceutical
13.4.1 Yangtze River Pharmaceutical Company Information
13.4.2 Yangtze River Pharmaceutical Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.4.3 Yangtze River Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Yangtze River Pharmaceutical Main Business Overview
13.4.5 Yangtze River Pharmaceutical Latest Developments
13.5 Qingfeng Pharmaceutical Group
13.5.1 Qingfeng Pharmaceutical Group Company Information
13.5.2 Qingfeng Pharmaceutical Group Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.5.3 Qingfeng Pharmaceutical Group Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Qingfeng Pharmaceutical Group Main Business Overview
13.5.5 Qingfeng Pharmaceutical Group Latest Developments
13.6 Qilu Pharmaceutical
13.6.1 Qilu Pharmaceutical Company Information
13.6.2 Qilu Pharmaceutical Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.6.3 Qilu Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Qilu Pharmaceutical Main Business Overview
13.6.5 Qilu Pharmaceutical Latest Developments
13.7 Kelun Pharmaceutical
13.7.1 Kelun Pharmaceutical Company Information
13.7.2 Kelun Pharmaceutical Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.7.3 Kelun Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Kelun Pharmaceutical Main Business Overview
13.7.5 Kelun Pharmaceutical Latest Developments
13.8 CSPC
13.8.1 CSPC Company Information
13.8.2 CSPC Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.8.3 CSPC Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CSPC Main Business Overview
13.8.5 CSPC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Afatinib Dimaleate Tablets Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Afatinib Dimaleate Tablets by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Afatinib Dimaleate Tablets by Country/Region, 2020, 2024 & 2031
2.2 Afatinib Dimaleate Tablets Segment by Type
2.2.1 30mg
2.2.2 40mg
2.2.3 Others
2.3 Afatinib Dimaleate Tablets Sales by Type
2.3.1 Global Afatinib Dimaleate Tablets Sales Market Share by Type (2020-2025)
2.3.2 Global Afatinib Dimaleate Tablets Revenue and Market Share by Type (2020-2025)
2.3.3 Global Afatinib Dimaleate Tablets Sale Price by Type (2020-2025)
2.4 Afatinib Dimaleate Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Afatinib Dimaleate Tablets Sales by Application
2.5.1 Global Afatinib Dimaleate Tablets Sale Market Share by Application (2020-2025)
2.5.2 Global Afatinib Dimaleate Tablets Revenue and Market Share by Application (2020-2025)
2.5.3 Global Afatinib Dimaleate Tablets Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Afatinib Dimaleate Tablets Breakdown Data by Company
3.1.1 Global Afatinib Dimaleate Tablets Annual Sales by Company (2020-2025)
3.1.2 Global Afatinib Dimaleate Tablets Sales Market Share by Company (2020-2025)
3.2 Global Afatinib Dimaleate Tablets Annual Revenue by Company (2020-2025)
3.2.1 Global Afatinib Dimaleate Tablets Revenue by Company (2020-2025)
3.2.2 Global Afatinib Dimaleate Tablets Revenue Market Share by Company (2020-2025)
3.3 Global Afatinib Dimaleate Tablets Sale Price by Company
3.4 Key Manufacturers Afatinib Dimaleate Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Afatinib Dimaleate Tablets Product Location Distribution
3.4.2 Players Afatinib Dimaleate Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AFATINIB DIMALEATE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Afatinib Dimaleate Tablets Market Size by Geographic Region (2020-2025)
4.1.1 Global Afatinib Dimaleate Tablets Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Afatinib Dimaleate Tablets Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Afatinib Dimaleate Tablets Market Size by Country/Region (2020-2025)
4.2.1 Global Afatinib Dimaleate Tablets Annual Sales by Country/Region (2020-2025)
4.2.2 Global Afatinib Dimaleate Tablets Annual Revenue by Country/Region (2020-2025)
4.3 Americas Afatinib Dimaleate Tablets Sales Growth
4.4 APAC Afatinib Dimaleate Tablets Sales Growth
4.5 Europe Afatinib Dimaleate Tablets Sales Growth
4.6 Middle East & Africa Afatinib Dimaleate Tablets Sales Growth
5 AMERICAS
5.1 Americas Afatinib Dimaleate Tablets Sales by Country
5.1.1 Americas Afatinib Dimaleate Tablets Sales by Country (2020-2025)
5.1.2 Americas Afatinib Dimaleate Tablets Revenue by Country (2020-2025)
5.2 Americas Afatinib Dimaleate Tablets Sales by Type (2020-2025)
5.3 Americas Afatinib Dimaleate Tablets Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Afatinib Dimaleate Tablets Sales by Region
6.1.1 APAC Afatinib Dimaleate Tablets Sales by Region (2020-2025)
6.1.2 APAC Afatinib Dimaleate Tablets Revenue by Region (2020-2025)
6.2 APAC Afatinib Dimaleate Tablets Sales by Type (2020-2025)
6.3 APAC Afatinib Dimaleate Tablets Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Afatinib Dimaleate Tablets by Country
7.1.1 Europe Afatinib Dimaleate Tablets Sales by Country (2020-2025)
7.1.2 Europe Afatinib Dimaleate Tablets Revenue by Country (2020-2025)
7.2 Europe Afatinib Dimaleate Tablets Sales by Type (2020-2025)
7.3 Europe Afatinib Dimaleate Tablets Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Afatinib Dimaleate Tablets by Country
8.1.1 Middle East & Africa Afatinib Dimaleate Tablets Sales by Country (2020-2025)
8.1.2 Middle East & Africa Afatinib Dimaleate Tablets Revenue by Country (2020-2025)
8.2 Middle East & Africa Afatinib Dimaleate Tablets Sales by Type (2020-2025)
8.3 Middle East & Africa Afatinib Dimaleate Tablets Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Afatinib Dimaleate Tablets
10.3 Manufacturing Process Analysis of Afatinib Dimaleate Tablets
10.4 Industry Chain Structure of Afatinib Dimaleate Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Afatinib Dimaleate Tablets Distributors
11.3 Afatinib Dimaleate Tablets Customer
12 WORLD FORECAST REVIEW FOR AFATINIB DIMALEATE TABLETS BY GEOGRAPHIC REGION
12.1 Global Afatinib Dimaleate Tablets Market Size Forecast by Region
12.1.1 Global Afatinib Dimaleate Tablets Forecast by Region (2026-2031)
12.1.2 Global Afatinib Dimaleate Tablets Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Afatinib Dimaleate Tablets Forecast by Type (2026-2031)
12.7 Global Afatinib Dimaleate Tablets Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Hansoh Pharmaceutical
13.2.1 Hansoh Pharmaceutical Company Information
13.2.2 Hansoh Pharmaceutical Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.2.3 Hansoh Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Hansoh Pharmaceutical Main Business Overview
13.2.5 Hansoh Pharmaceutical Latest Developments
13.3 Chia Tai Tianqing Pharmaceutical
13.3.1 Chia Tai Tianqing Pharmaceutical Company Information
13.3.2 Chia Tai Tianqing Pharmaceutical Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.3.3 Chia Tai Tianqing Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Chia Tai Tianqing Pharmaceutical Main Business Overview
13.3.5 Chia Tai Tianqing Pharmaceutical Latest Developments
13.4 Yangtze River Pharmaceutical
13.4.1 Yangtze River Pharmaceutical Company Information
13.4.2 Yangtze River Pharmaceutical Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.4.3 Yangtze River Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Yangtze River Pharmaceutical Main Business Overview
13.4.5 Yangtze River Pharmaceutical Latest Developments
13.5 Qingfeng Pharmaceutical Group
13.5.1 Qingfeng Pharmaceutical Group Company Information
13.5.2 Qingfeng Pharmaceutical Group Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.5.3 Qingfeng Pharmaceutical Group Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Qingfeng Pharmaceutical Group Main Business Overview
13.5.5 Qingfeng Pharmaceutical Group Latest Developments
13.6 Qilu Pharmaceutical
13.6.1 Qilu Pharmaceutical Company Information
13.6.2 Qilu Pharmaceutical Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.6.3 Qilu Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Qilu Pharmaceutical Main Business Overview
13.6.5 Qilu Pharmaceutical Latest Developments
13.7 Kelun Pharmaceutical
13.7.1 Kelun Pharmaceutical Company Information
13.7.2 Kelun Pharmaceutical Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.7.3 Kelun Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Kelun Pharmaceutical Main Business Overview
13.7.5 Kelun Pharmaceutical Latest Developments
13.8 CSPC
13.8.1 CSPC Company Information
13.8.2 CSPC Afatinib Dimaleate Tablets Product Portfolios and Specifications
13.8.3 CSPC Afatinib Dimaleate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CSPC Main Business Overview
13.8.5 CSPC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Afatinib DimaleateTablets Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Afatinib DimaleateTablets Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 30mg
Table 4. Major Players of 40mg
Table 5. Major Players of Others
Table 6. Global Afatinib DimaleateTablets Sales by Type (2020-2025) & (kg)
Table 7. Global Afatinib DimaleateTablets Sales Market Share by Type (2020-2025)
Table 8. Global Afatinib DimaleateTablets Revenue by Type (2020-2025) & ($ million)
Table 9. Global Afatinib DimaleateTablets Revenue Market Share by Type (2020-2025)
Table 10. Global Afatinib DimaleateTablets Sale Price by Type (2020-2025) & (US$/g)
Table 11. Global Afatinib DimaleateTablets Sale by Application (2020-2025) & (kg)
Table 12. Global Afatinib DimaleateTablets Sale Market Share by Application (2020-2025)
Table 13. Global Afatinib DimaleateTablets Revenue by Application (2020-2025) & ($ million)
Table 14. Global Afatinib DimaleateTablets Revenue Market Share by Application (2020-2025)
Table 15. Global Afatinib DimaleateTablets Sale Price by Application (2020-2025) & (US$/g)
Table 16. Global Afatinib DimaleateTablets Sales by Company (2020-2025) & (kg)
Table 17. Global Afatinib DimaleateTablets Sales Market Share by Company (2020-2025)
Table 18. Global Afatinib DimaleateTablets Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Afatinib DimaleateTablets Revenue Market Share by Company (2020-2025)
Table 20. Global Afatinib DimaleateTablets Sale Price by Company (2020-2025) & (US$/g)
Table 21. Key Manufacturers Afatinib DimaleateTablets Producing Area Distribution and Sales Area
Table 22. Players Afatinib DimaleateTablets Products Offered
Table 23. Afatinib DimaleateTablets Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Afatinib DimaleateTablets Sales by Geographic Region (2020-2025) & (kg)
Table 27. Global Afatinib DimaleateTablets Sales Market Share Geographic Region (2020-2025)
Table 28. Global Afatinib DimaleateTablets Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Afatinib DimaleateTablets Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Afatinib DimaleateTablets Sales by Country/Region (2020-2025) & (kg)
Table 31. Global Afatinib DimaleateTablets Sales Market Share by Country/Region (2020-2025)
Table 32. Global Afatinib DimaleateTablets Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Afatinib DimaleateTablets Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Afatinib DimaleateTablets Sales by Country (2020-2025) & (kg)
Table 35. Americas Afatinib DimaleateTablets Sales Market Share by Country (2020-2025)
Table 36. Americas Afatinib DimaleateTablets Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Afatinib DimaleateTablets Sales by Type (2020-2025) & (kg)
Table 38. Americas Afatinib DimaleateTablets Sales by Application (2020-2025) & (kg)
Table 39. APAC Afatinib DimaleateTablets Sales by Region (2020-2025) & (kg)
Table 40. APAC Afatinib DimaleateTablets Sales Market Share by Region (2020-2025)
Table 41. APAC Afatinib DimaleateTablets Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Afatinib DimaleateTablets Sales by Type (2020-2025) & (kg)
Table 43. APAC Afatinib DimaleateTablets Sales by Application (2020-2025) & (kg)
Table 44. Europe Afatinib DimaleateTablets Sales by Country (2020-2025) & (kg)
Table 45. Europe Afatinib DimaleateTablets Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Afatinib DimaleateTablets Sales by Type (2020-2025) & (kg)
Table 47. Europe Afatinib DimaleateTablets Sales by Application (2020-2025) & (kg)
Table 48. Middle East & Africa Afatinib DimaleateTablets Sales by Country (2020-2025) & (kg)
Table 49. Middle East & Africa Afatinib DimaleateTablets Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Afatinib DimaleateTablets Sales by Type (2020-2025) & (kg)
Table 51. Middle East & Africa Afatinib DimaleateTablets Sales by Application (2020-2025) & (kg)
Table 52. Key Market Drivers & Growth Opportunities of Afatinib DimaleateTablets
Table 53. Key Market Challenges & Risks of Afatinib DimaleateTablets
Table 54. Key Industry Trends of Afatinib DimaleateTablets
Table 55. Afatinib DimaleateTablets Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Afatinib DimaleateTablets Distributors List
Table 58. Afatinib DimaleateTablets Customer List
Table 59. Global Afatinib DimaleateTablets Sales Forecast by Region (2026-2031) & (kg)
Table 60. Global Afatinib DimaleateTablets Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Afatinib DimaleateTablets Sales Forecast by Country (2026-2031) & (kg)
Table 62. Americas Afatinib DimaleateTablets Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Afatinib DimaleateTablets Sales Forecast by Region (2026-2031) & (kg)
Table 64. APAC Afatinib DimaleateTablets Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Afatinib DimaleateTablets Sales Forecast by Country (2026-2031) & (kg)
Table 66. Europe Afatinib DimaleateTablets Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Afatinib DimaleateTablets Sales Forecast by Country (2026-2031) & (kg)
Table 68. Middle East & Africa Afatinib DimaleateTablets Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Afatinib DimaleateTablets Sales Forecast by Type (2026-2031) & (kg)
Table 70. Global Afatinib DimaleateTablets Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Afatinib DimaleateTablets Sales Forecast by Application (2026-2031) & (kg)
Table 72. Global Afatinib DimaleateTablets Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Boehringer Ingelheim Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 74. Boehringer Ingelheim Afatinib DimaleateTablets Product Portfolios and Specifications
Table 75. Boehringer Ingelheim Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 76. Boehringer Ingelheim Main Business
Table 77. Boehringer Ingelheim Latest Developments
Table 78. Hansoh Pharmaceutical Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 79. Hansoh Pharmaceutical Afatinib DimaleateTablets Product Portfolios and Specifications
Table 80. Hansoh Pharmaceutical Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 81. Hansoh Pharmaceutical Main Business
Table 82. Hansoh Pharmaceutical Latest Developments
Table 83. Chia Tai Tianqing Pharmaceutical Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 84. Chia Tai Tianqing Pharmaceutical Afatinib DimaleateTablets Product Portfolios and Specifications
Table 85. Chia Tai Tianqing Pharmaceutical Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 86. Chia Tai Tianqing Pharmaceutical Main Business
Table 87. Chia Tai Tianqing Pharmaceutical Latest Developments
Table 88. Yangtze River Pharmaceutical Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 89. Yangtze River Pharmaceutical Afatinib DimaleateTablets Product Portfolios and Specifications
Table 90. Yangtze River Pharmaceutical Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 91. Yangtze River Pharmaceutical Main Business
Table 92. Yangtze River Pharmaceutical Latest Developments
Table 93. Qingfeng Pharmaceutical Group Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 94. Qingfeng Pharmaceutical Group Afatinib DimaleateTablets Product Portfolios and Specifications
Table 95. Qingfeng Pharmaceutical Group Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 96. Qingfeng Pharmaceutical Group Main Business
Table 97. Qingfeng Pharmaceutical Group Latest Developments
Table 98. Qilu Pharmaceutical Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Qilu Pharmaceutical Afatinib DimaleateTablets Product Portfolios and Specifications
Table 100. Qilu Pharmaceutical Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 101. Qilu Pharmaceutical Main Business
Table 102. Qilu Pharmaceutical Latest Developments
Table 103. Kelun Pharmaceutical Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Kelun Pharmaceutical Afatinib DimaleateTablets Product Portfolios and Specifications
Table 105. Kelun Pharmaceutical Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 106. Kelun Pharmaceutical Main Business
Table 107. Kelun Pharmaceutical Latest Developments
Table 108. CSPC Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 109. CSPC Afatinib DimaleateTablets Product Portfolios and Specifications
Table 110. CSPC Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 111. CSPC Main Business
Table 112. CSPC Latest Developments
Table 1. Afatinib DimaleateTablets Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Afatinib DimaleateTablets Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 30mg
Table 4. Major Players of 40mg
Table 5. Major Players of Others
Table 6. Global Afatinib DimaleateTablets Sales by Type (2020-2025) & (kg)
Table 7. Global Afatinib DimaleateTablets Sales Market Share by Type (2020-2025)
Table 8. Global Afatinib DimaleateTablets Revenue by Type (2020-2025) & ($ million)
Table 9. Global Afatinib DimaleateTablets Revenue Market Share by Type (2020-2025)
Table 10. Global Afatinib DimaleateTablets Sale Price by Type (2020-2025) & (US$/g)
Table 11. Global Afatinib DimaleateTablets Sale by Application (2020-2025) & (kg)
Table 12. Global Afatinib DimaleateTablets Sale Market Share by Application (2020-2025)
Table 13. Global Afatinib DimaleateTablets Revenue by Application (2020-2025) & ($ million)
Table 14. Global Afatinib DimaleateTablets Revenue Market Share by Application (2020-2025)
Table 15. Global Afatinib DimaleateTablets Sale Price by Application (2020-2025) & (US$/g)
Table 16. Global Afatinib DimaleateTablets Sales by Company (2020-2025) & (kg)
Table 17. Global Afatinib DimaleateTablets Sales Market Share by Company (2020-2025)
Table 18. Global Afatinib DimaleateTablets Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Afatinib DimaleateTablets Revenue Market Share by Company (2020-2025)
Table 20. Global Afatinib DimaleateTablets Sale Price by Company (2020-2025) & (US$/g)
Table 21. Key Manufacturers Afatinib DimaleateTablets Producing Area Distribution and Sales Area
Table 22. Players Afatinib DimaleateTablets Products Offered
Table 23. Afatinib DimaleateTablets Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Afatinib DimaleateTablets Sales by Geographic Region (2020-2025) & (kg)
Table 27. Global Afatinib DimaleateTablets Sales Market Share Geographic Region (2020-2025)
Table 28. Global Afatinib DimaleateTablets Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Afatinib DimaleateTablets Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Afatinib DimaleateTablets Sales by Country/Region (2020-2025) & (kg)
Table 31. Global Afatinib DimaleateTablets Sales Market Share by Country/Region (2020-2025)
Table 32. Global Afatinib DimaleateTablets Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Afatinib DimaleateTablets Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Afatinib DimaleateTablets Sales by Country (2020-2025) & (kg)
Table 35. Americas Afatinib DimaleateTablets Sales Market Share by Country (2020-2025)
Table 36. Americas Afatinib DimaleateTablets Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Afatinib DimaleateTablets Sales by Type (2020-2025) & (kg)
Table 38. Americas Afatinib DimaleateTablets Sales by Application (2020-2025) & (kg)
Table 39. APAC Afatinib DimaleateTablets Sales by Region (2020-2025) & (kg)
Table 40. APAC Afatinib DimaleateTablets Sales Market Share by Region (2020-2025)
Table 41. APAC Afatinib DimaleateTablets Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Afatinib DimaleateTablets Sales by Type (2020-2025) & (kg)
Table 43. APAC Afatinib DimaleateTablets Sales by Application (2020-2025) & (kg)
Table 44. Europe Afatinib DimaleateTablets Sales by Country (2020-2025) & (kg)
Table 45. Europe Afatinib DimaleateTablets Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Afatinib DimaleateTablets Sales by Type (2020-2025) & (kg)
Table 47. Europe Afatinib DimaleateTablets Sales by Application (2020-2025) & (kg)
Table 48. Middle East & Africa Afatinib DimaleateTablets Sales by Country (2020-2025) & (kg)
Table 49. Middle East & Africa Afatinib DimaleateTablets Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Afatinib DimaleateTablets Sales by Type (2020-2025) & (kg)
Table 51. Middle East & Africa Afatinib DimaleateTablets Sales by Application (2020-2025) & (kg)
Table 52. Key Market Drivers & Growth Opportunities of Afatinib DimaleateTablets
Table 53. Key Market Challenges & Risks of Afatinib DimaleateTablets
Table 54. Key Industry Trends of Afatinib DimaleateTablets
Table 55. Afatinib DimaleateTablets Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Afatinib DimaleateTablets Distributors List
Table 58. Afatinib DimaleateTablets Customer List
Table 59. Global Afatinib DimaleateTablets Sales Forecast by Region (2026-2031) & (kg)
Table 60. Global Afatinib DimaleateTablets Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Afatinib DimaleateTablets Sales Forecast by Country (2026-2031) & (kg)
Table 62. Americas Afatinib DimaleateTablets Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Afatinib DimaleateTablets Sales Forecast by Region (2026-2031) & (kg)
Table 64. APAC Afatinib DimaleateTablets Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Afatinib DimaleateTablets Sales Forecast by Country (2026-2031) & (kg)
Table 66. Europe Afatinib DimaleateTablets Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Afatinib DimaleateTablets Sales Forecast by Country (2026-2031) & (kg)
Table 68. Middle East & Africa Afatinib DimaleateTablets Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Afatinib DimaleateTablets Sales Forecast by Type (2026-2031) & (kg)
Table 70. Global Afatinib DimaleateTablets Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Afatinib DimaleateTablets Sales Forecast by Application (2026-2031) & (kg)
Table 72. Global Afatinib DimaleateTablets Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Boehringer Ingelheim Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 74. Boehringer Ingelheim Afatinib DimaleateTablets Product Portfolios and Specifications
Table 75. Boehringer Ingelheim Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 76. Boehringer Ingelheim Main Business
Table 77. Boehringer Ingelheim Latest Developments
Table 78. Hansoh Pharmaceutical Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 79. Hansoh Pharmaceutical Afatinib DimaleateTablets Product Portfolios and Specifications
Table 80. Hansoh Pharmaceutical Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 81. Hansoh Pharmaceutical Main Business
Table 82. Hansoh Pharmaceutical Latest Developments
Table 83. Chia Tai Tianqing Pharmaceutical Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 84. Chia Tai Tianqing Pharmaceutical Afatinib DimaleateTablets Product Portfolios and Specifications
Table 85. Chia Tai Tianqing Pharmaceutical Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 86. Chia Tai Tianqing Pharmaceutical Main Business
Table 87. Chia Tai Tianqing Pharmaceutical Latest Developments
Table 88. Yangtze River Pharmaceutical Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 89. Yangtze River Pharmaceutical Afatinib DimaleateTablets Product Portfolios and Specifications
Table 90. Yangtze River Pharmaceutical Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 91. Yangtze River Pharmaceutical Main Business
Table 92. Yangtze River Pharmaceutical Latest Developments
Table 93. Qingfeng Pharmaceutical Group Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 94. Qingfeng Pharmaceutical Group Afatinib DimaleateTablets Product Portfolios and Specifications
Table 95. Qingfeng Pharmaceutical Group Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 96. Qingfeng Pharmaceutical Group Main Business
Table 97. Qingfeng Pharmaceutical Group Latest Developments
Table 98. Qilu Pharmaceutical Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Qilu Pharmaceutical Afatinib DimaleateTablets Product Portfolios and Specifications
Table 100. Qilu Pharmaceutical Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 101. Qilu Pharmaceutical Main Business
Table 102. Qilu Pharmaceutical Latest Developments
Table 103. Kelun Pharmaceutical Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Kelun Pharmaceutical Afatinib DimaleateTablets Product Portfolios and Specifications
Table 105. Kelun Pharmaceutical Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 106. Kelun Pharmaceutical Main Business
Table 107. Kelun Pharmaceutical Latest Developments
Table 108. CSPC Basic Information, Afatinib DimaleateTablets Manufacturing Base, Sales Area and Its Competitors
Table 109. CSPC Afatinib DimaleateTablets Product Portfolios and Specifications
Table 110. CSPC Afatinib DimaleateTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 111. CSPC Main Business
Table 112. CSPC Latest Developments
LIST OF FIGURES
Figure 1. Picture of Afatinib DimaleateTablets
Figure 2. Afatinib DimaleateTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Afatinib DimaleateTablets Sales Growth Rate 2020-2031 (kg)
Figure 7. Global Afatinib DimaleateTablets Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Afatinib DimaleateTablets Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Afatinib DimaleateTablets Sales Market Share by Country/Region (2024)
Figure 10. Afatinib DimaleateTablets Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 30mg
Figure 12. Product Picture of 40mg
Figure 13. Product Picture of Others
Figure 14. Global Afatinib DimaleateTablets Sales Market Share by Type in 2025
Figure 15. Global Afatinib DimaleateTablets Revenue Market Share by Type (2020-2025)
Figure 16. Afatinib DimaleateTablets Consumed in Hospital
Figure 17. Global Afatinib DimaleateTablets Market: Hospital (2020-2025) & (kg)
Figure 18. Afatinib DimaleateTablets Consumed in Clinic
Figure 19. Global Afatinib DimaleateTablets Market: Clinic (2020-2025) & (kg)
Figure 20. Afatinib DimaleateTablets Consumed in Others
Figure 21. Global Afatinib DimaleateTablets Market: Others (2020-2025) & (kg)
Figure 22. Global Afatinib DimaleateTablets Sale Market Share by Application (2024)
Figure 23. Global Afatinib DimaleateTablets Revenue Market Share by Application in 2025
Figure 24. Afatinib DimaleateTablets Sales by Company in 2025 (kg)
Figure 25. Global Afatinib DimaleateTablets Sales Market Share by Company in 2025
Figure 26. Afatinib DimaleateTablets Revenue by Company in 2025 ($ millions)
Figure 27. Global Afatinib DimaleateTablets Revenue Market Share by Company in 2025
Figure 28. Global Afatinib DimaleateTablets Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Afatinib DimaleateTablets Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Afatinib DimaleateTablets Sales 2020-2025 (kg)
Figure 31. Americas Afatinib DimaleateTablets Revenue 2020-2025 ($ millions)
Figure 32. APAC Afatinib DimaleateTablets Sales 2020-2025 (kg)
Figure 33. APAC Afatinib DimaleateTablets Revenue 2020-2025 ($ millions)
Figure 34. Europe Afatinib DimaleateTablets Sales 2020-2025 (kg)
Figure 35. Europe Afatinib DimaleateTablets Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Afatinib DimaleateTablets Sales 2020-2025 (kg)
Figure 37. Middle East & Africa Afatinib DimaleateTablets Revenue 2020-2025 ($ millions)
Figure 38. Americas Afatinib DimaleateTablets Sales Market Share by Country in 2025
Figure 39. Americas Afatinib DimaleateTablets Revenue Market Share by Country (2020-2025)
Figure 40. Americas Afatinib DimaleateTablets Sales Market Share by Type (2020-2025)
Figure 41. Americas Afatinib DimaleateTablets Sales Market Share by Application (2020-2025)
Figure 42. United States Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Afatinib DimaleateTablets Sales Market Share by Region in 2025
Figure 47. APAC Afatinib DimaleateTablets Revenue Market Share by Region (2020-2025)
Figure 48. APAC Afatinib DimaleateTablets Sales Market Share by Type (2020-2025)
Figure 49. APAC Afatinib DimaleateTablets Sales Market Share by Application (2020-2025)
Figure 50. China Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 54. India Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Afatinib DimaleateTablets Sales Market Share by Country in 2025
Figure 58. Europe Afatinib DimaleateTablets Revenue Market Share by Country (2020-2025)
Figure 59. Europe Afatinib DimaleateTablets Sales Market Share by Type (2020-2025)
Figure 60. Europe Afatinib DimaleateTablets Sales Market Share by Application (2020-2025)
Figure 61. Germany Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 62. France Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Afatinib DimaleateTablets Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Afatinib DimaleateTablets Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Afatinib DimaleateTablets Sales Market Share by Application (2020-2025)
Figure 69. Egypt Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Afatinib DimaleateTablets in 2025
Figure 75. Manufacturing Process Analysis of Afatinib DimaleateTablets
Figure 76. Industry Chain Structure of Afatinib DimaleateTablets
Figure 77. Channels of Distribution
Figure 78. Global Afatinib DimaleateTablets Sales Market Forecast by Region (2026-2031)
Figure 79. Global Afatinib DimaleateTablets Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Afatinib DimaleateTablets Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Afatinib DimaleateTablets Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Afatinib DimaleateTablets Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Afatinib DimaleateTablets Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Afatinib DimaleateTablets
Figure 2. Afatinib DimaleateTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Afatinib DimaleateTablets Sales Growth Rate 2020-2031 (kg)
Figure 7. Global Afatinib DimaleateTablets Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Afatinib DimaleateTablets Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Afatinib DimaleateTablets Sales Market Share by Country/Region (2024)
Figure 10. Afatinib DimaleateTablets Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 30mg
Figure 12. Product Picture of 40mg
Figure 13. Product Picture of Others
Figure 14. Global Afatinib DimaleateTablets Sales Market Share by Type in 2025
Figure 15. Global Afatinib DimaleateTablets Revenue Market Share by Type (2020-2025)
Figure 16. Afatinib DimaleateTablets Consumed in Hospital
Figure 17. Global Afatinib DimaleateTablets Market: Hospital (2020-2025) & (kg)
Figure 18. Afatinib DimaleateTablets Consumed in Clinic
Figure 19. Global Afatinib DimaleateTablets Market: Clinic (2020-2025) & (kg)
Figure 20. Afatinib DimaleateTablets Consumed in Others
Figure 21. Global Afatinib DimaleateTablets Market: Others (2020-2025) & (kg)
Figure 22. Global Afatinib DimaleateTablets Sale Market Share by Application (2024)
Figure 23. Global Afatinib DimaleateTablets Revenue Market Share by Application in 2025
Figure 24. Afatinib DimaleateTablets Sales by Company in 2025 (kg)
Figure 25. Global Afatinib DimaleateTablets Sales Market Share by Company in 2025
Figure 26. Afatinib DimaleateTablets Revenue by Company in 2025 ($ millions)
Figure 27. Global Afatinib DimaleateTablets Revenue Market Share by Company in 2025
Figure 28. Global Afatinib DimaleateTablets Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Afatinib DimaleateTablets Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Afatinib DimaleateTablets Sales 2020-2025 (kg)
Figure 31. Americas Afatinib DimaleateTablets Revenue 2020-2025 ($ millions)
Figure 32. APAC Afatinib DimaleateTablets Sales 2020-2025 (kg)
Figure 33. APAC Afatinib DimaleateTablets Revenue 2020-2025 ($ millions)
Figure 34. Europe Afatinib DimaleateTablets Sales 2020-2025 (kg)
Figure 35. Europe Afatinib DimaleateTablets Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Afatinib DimaleateTablets Sales 2020-2025 (kg)
Figure 37. Middle East & Africa Afatinib DimaleateTablets Revenue 2020-2025 ($ millions)
Figure 38. Americas Afatinib DimaleateTablets Sales Market Share by Country in 2025
Figure 39. Americas Afatinib DimaleateTablets Revenue Market Share by Country (2020-2025)
Figure 40. Americas Afatinib DimaleateTablets Sales Market Share by Type (2020-2025)
Figure 41. Americas Afatinib DimaleateTablets Sales Market Share by Application (2020-2025)
Figure 42. United States Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Afatinib DimaleateTablets Sales Market Share by Region in 2025
Figure 47. APAC Afatinib DimaleateTablets Revenue Market Share by Region (2020-2025)
Figure 48. APAC Afatinib DimaleateTablets Sales Market Share by Type (2020-2025)
Figure 49. APAC Afatinib DimaleateTablets Sales Market Share by Application (2020-2025)
Figure 50. China Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 54. India Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Afatinib DimaleateTablets Sales Market Share by Country in 2025
Figure 58. Europe Afatinib DimaleateTablets Revenue Market Share by Country (2020-2025)
Figure 59. Europe Afatinib DimaleateTablets Sales Market Share by Type (2020-2025)
Figure 60. Europe Afatinib DimaleateTablets Sales Market Share by Application (2020-2025)
Figure 61. Germany Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 62. France Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Afatinib DimaleateTablets Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Afatinib DimaleateTablets Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Afatinib DimaleateTablets Sales Market Share by Application (2020-2025)
Figure 69. Egypt Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Afatinib DimaleateTablets Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Afatinib DimaleateTablets in 2025
Figure 75. Manufacturing Process Analysis of Afatinib DimaleateTablets
Figure 76. Industry Chain Structure of Afatinib DimaleateTablets
Figure 77. Channels of Distribution
Figure 78. Global Afatinib DimaleateTablets Sales Market Forecast by Region (2026-2031)
Figure 79. Global Afatinib DimaleateTablets Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Afatinib DimaleateTablets Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Afatinib DimaleateTablets Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Afatinib DimaleateTablets Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Afatinib DimaleateTablets Revenue Market Share Forecast by Application (2026-2031)
